Evidence map›Paper›PMID 39590015›Full record

ReviewBiosensors2024

Commercial Wearables for the Management of People with Autism Spectrum Disorder: A Review.

Jonathan Hernández-Capistrán, Giner Alor-Hernández, Humberto Marín-Vega, Maritza Bustos-López, Laura Nely Sanchez-Morales, Jose Luis Sanchez-Cervantes

Abstract readReview
In one paragraph

Review in Biosensors, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jonathan Hernández-CapistránTecnológico Nacional de México/I.T. Orizaba, Av. Oriente 9, 852. Col. Emiliano Zapata, Orizaba C.P. 94320, Veracruz, Mexico.
Giner Alor-HernándezTecnológico Nacional de México/I.T. Orizaba, Av. Oriente 9, 852. Col. Emiliano Zapata, Orizaba C.P. 94320, Veracruz, Mexico.ORCID 0000-0003-3296-0981
Humberto Marín-VegaTecnológico Nacional de México/I.T. Orizaba, Av. Oriente 9, 852. Col. Emiliano Zapata, Orizaba C.P. 94320, Veracruz, Mexico.
Maritza Bustos-LópezTecnológico Nacional de México/I.T. Orizaba, Av. Oriente 9, 852. Col. Emiliano Zapata, Orizaba C.P. 94320, Veracruz, Mexico.
Laura Nely Sanchez-MoralesCONAHCYT-Tecnológico Nacional de México/I.T. Orizaba, Av. Oriente 9, 852. Col. Emiliano Zapata, Orizaba C.P. 94320, Veracruz, Mexico.
Jose Luis Sanchez-CervantesTecnológico Nacional de México/I.T. Orizaba, Av. Oriente 9, 852. Col. Emiliano Zapata, Orizaba C.P. 94320, Veracruz, Mexico.ORCID 0000-0001-5194-1263

Funding

Conahcyt 2256876
6 · The paper itself

Abstract

Autism Spectrum Disorder (ASD) necessitates comprehensive management, addressing complex challenges in social communication, behavioral regulation, and sensory processing, for which wearable technologies offer valuable tools to monitor and support interventions. Therefore, this review explores recent advancements in wearable technology, categorizing devices based on executive function, psychomotor skills, and the behavioral/emotional/sensory domain, highlighting their potential to improve ongoing management and intervention. To ensure rigor and comprehensiveness, the review employs a PRISMA-based methodology. Specifically, literature searches were conducted across diverse databases, focusing on studies published between 2014 and 2024, to identify the most commonly used wearables in ASD research. Notably, 55.45% of the 110 devices analyzed had an undefined FDA status, 23.6% received 510(k) clearance, and only a small percentage were classified as FDA Breakthrough Devices or in the submission process. Additionally, approximately 50% of the devices utilized sensors like ECG, EEG, PPG, and EMG, highlighting their widespread use in real-time physiological monitoring. Our work comprehensively analyzes a wide array of wearable technologies, including emerging and advanced. While these technologies have the potential to transform ASD management through real-time data collection and personalized interventions, improved clinical validation and user-centered design are essential for maximizing their effectiveness and user acceptance.

Indexed as

Autism Spectrum DisorderWearable Electronic DevicesHumansMonitoring, Physiologicautism spectrum disorderphysiologicalsensorswearables

Identifiers

PMID39590015
PMCPMC11591563

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.